Global Health and IP

Scientific and technological innovation has contributed to significant advances in public health. The challenge for policymakers is to establish an environment that stimulates health innovation while ensuring widespread access to new, more effective products to address unmet global health needs.

WIPO’s Global Challenges program seeks to raise awareness and understanding of the complex linkages between global health and access to medical technologies, innovation, technology transfer and trade. The goal is to leverage intellectual property (IP) as a tool that contributes to meeting the world’s most pressing health needs.

Featured

WHO, WIPO & WTO Trilateral Symposium 2022

The Joint Technical Symposium held on 16 December by the World Health Organization (WHO), World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO) highlighted that the world can move quickly when driven by a crisis situation, such as the COVID-19 pandemic.

News item | Meeting documents

Less than 1% of vaccines used in Africa are manufactured locally, but the need for immunization continues to grow. In this episode of WIPO’s Mission Imagination series, Mr. Patrick Tippoo, Chief Science and Innovation Officer at South Africa-based Biovac, and Executive Director and founding member of the African Vaccine Manufacturing Initiative (AVMI), shares insights on what it takes to build sustainable vaccine manufacturing ecosystems.

Watch on YouTube

Dr. Richard Hatchett – CEO of the Coalition for Epidemic Preparedness Innovations (CEPI) talks about CEPI’s multistakeholder approach to develop vaccines for deadly diseases as well as for diseases that may not even exist yet in this episode of WIPO’s Mission Imagination series.

Watch on YouTube

Dr. Peter Hotez led the development of Corbevax, an affordable and accessible “patent-free” COVID-19 vaccine. Watch the interview in the inaugural episode of WIPO’s Mission Imagination series.

Watch on YouTube